Technical Analysis for BLFS - BioLife Solutions, Inc.

Grade Last Price % Change Price Change
B 17.53 3.97% 0.67
BLFS closed up 3.97 percent on Friday, April 26, 2024, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: May 8
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Fell Below 20 DMA Bearish 3.97%
Gapped Down Weakness 3.97%
50 DMA Resistance Bearish 1.98%
Shooting Star Candlestick Bearish 1.98%
Crossed Above 20 DMA Bullish 1.98%
MACD Bullish Signal Line Cross Bullish 1.98%
Pocket Pivot Bullish Swing Setup 1.98%
Doji - Bearish? Reversal 1.98%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 16 hours ago
Up 3% about 16 hours ago
50 DMA Resistance about 20 hours ago
Rose Above 50 DMA about 20 hours ago
Rose Above Previous Day's High about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioLife Solutions, Inc. Description

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company’s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it’s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Life Sciences Pharmaceutical Biology Drug Discovery Stem Cell Cell Biology Regenerative Medicine Packaging Products Toxicology Organs Blood Adult Stem Cell Media Products Childbirth Cord Blood Organ Transplantation Packaging Services Toxicology Testing Cryopreservation

Is BLFS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.5
52 Week Low 8.9201
Average Volume 395,245
200-Day Moving Average 15.25
50-Day Moving Average 17.34
20-Day Moving Average 16.89
10-Day Moving Average 16.39
Average True Range 1.01
RSI (14) 54.34
ADX 13.4
+DI 22.58
-DI 20.52
Chandelier Exit (Long, 3 ATRs) 16.00
Chandelier Exit (Short, 3 ATRs) 17.87
Upper Bollinger Bands 18.45
Lower Bollinger Band 15.32
Percent B (%b) 0.71
BandWidth 18.53
MACD Line -0.17
MACD Signal Line -0.28
MACD Histogram 0.1103
Fundamentals Value
Market Cap 789.68 Million
Num Shares 45 Million
EPS -2.37
Price-to-Earnings (P/E) Ratio -7.40
Price-to-Sales 5.48
Price-to-Book 2.53
PEG Ratio 63.20
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.24
Resistance 3 (R3) 19.06 18.30 18.96
Resistance 2 (R2) 18.30 17.87 18.40 18.86
Resistance 1 (R1) 17.92 17.60 18.11 18.10 18.76
Pivot Point 17.16 17.16 17.26 17.26 17.16
Support 1 (S1) 16.78 16.73 16.97 16.96 16.30
Support 2 (S2) 16.02 16.46 16.12 16.20
Support 3 (S3) 15.64 16.02 16.11
Support 4 (S4) 15.82